Status
Conditions
Treatments
About
The VEW (Vomiting, Eating, and Weight Loss) Questionnaire has been developed as a method for the assessment of post bariatric surgery patients, as well as a research tool into the eating behaviour of these patients.
Objective VEW Questionnaire Premise If used optimally the VEW score is a valuable tool for patients who have had Laparoscopic Gastric Band Surgery (LAGB). The VEW score will be able to assist clinicians treating patients with a LAGB, specifically the Swedish Adjustable Gastric Band (SAGB), by providing them a tool to enhance patient outcomes. By using the information gained from the VEW questionnaire we can assess many areas of the eating behavior, and adjustment outcomes in patients with Gastric Bands.
Hypotheses:
The VEW questionnaire aids in the assessment of the need for gastric band adjustment (up or down in volume)
Comparison of patient factors in those who have had a
In patients who have had a bad outcome, which factors are more predictive?
Fewer Complications associated with Gastric Band Adjustments
Eating behavior can predict long term outcomes
o By comparison of factors in the different quartiles of weight loss (particularly top 25% cf. bottom 25%)
Maintenance of weight loss after 12 months is best achieved by use of behavior modification via improved food tolerances and better eating behavior than by increasing restriction of the band by further adjustments. 12 months is chosen as an arbitrary time where the majority of expected weight loss (45% of expected 50-55% 0f EWL) has been achieved. It is also a time frame by which patients have learnt to use the band appropriately, and the gastric band has had time to be adjusted into its optimal range.
The VEW questionnaire can help predict poor outcomes from a SAGB adjustment.
Full description
The VEW (Vomiting, Eating, and Weight Loss) Questionnaire has been developed as a method for the assessment of post bariatric surgery patients, as well as a research tool into the eating behaviour of these patients.
Objective VEW Questionnaire Premise If used optimally the VEW score is a valuable tool for patients who have had Laparoscopic Gastric Band Surgery (LAGB). The VEW score will be able to assist clinicians treating patients with a LAGB, specifically the Swedish Adjustable Gastric Band (SAGB), by providing them a tool to enhance patient outcomes. By using the information gained from the VEW questionnaire we can assess many areas of the eating behavior, and adjustment outcomes in patients with Gastric Bands.
Hypotheses:
The VEW questionnaire aids in the assessment of the need for gastric band adjustment (up or down in volume)
o Comparison of patient factors in those who have had a
Fewer Complications associated with Gastric Band Adjustments o Obstruction o Need for urgent deflation
o Pain on eating
Eating behavior can predict long term outcomes
Maintenance of weight loss after 12 months is best achieved by use of behavior modification via improved food tolerances and better eating behavior than by increasing restriction of the band by further adjustments. 12 months is chosen as an arbitrary time where the majority of expected weight loss (45% of expected 50-55% 0f EWL) has been achieved. It is also a time frame by which patients have learnt to use the band appropriately, and the gastric band has had time to be adjusted into its optimal range.
The VEW questionnaire can help predict poor outcomes from a SAGB adjustment.
By analyzing the factors in patients who have returned both acutely (days) or at subsequent visits (weeks) and had fluid removed from their bands. These factors would include pain, vomiting, length of meals, maladaption score, fluid added, etc.
Study Population, including Inclusion/Exclusion There are 507 patients that are eligible for inclusion to this study. The patients that will be included are only those patients that are eligible for a LAGB adjustment (thus excluding preoperative and the first post-operative visit) and have presented for review by the treating surgeon (single surgeon) in the year 2009. All non-gastric band and non-SAGB gastric bands have been excluded. Assessments by dietitians and psychologists have also been excluded.
Study Procedures Initial Patient consent for the VEW questionnaire is obtained in consultation with the treating surgeon and dietician where the expectation, benefits and knowledge are explained and confirmed. This occurs prior to the need for adjustments, that is, during the preoperative period. To date there have been no patients that have not participated with the questionnaire.
The VEW questionnaire is handed out to all eligible (please see description for eligibility in point three) upon arrival to the clinic. Patients are given five minutes to fill out the questionnaire which is then brought into the consultation with them.
Patient care and treatment is done with the strictest adherence to the Declaration of Helsinki and in the aim of developing new and better guidelines for Best Practice for the treatment of patients who have had a LAGB.
Duration of Study Twelve months starting 1st January 2009-31st December 2009.
Procedure Type
The VEW score study is limited to patients that have had LAGB specifically the Swedish Adjustable Gastric Band (SAGB):
o SAGB -VC
SABG -QC
SAGB - 2100 The VEW questionnaire is used following all bariatric procedures but the study would be limited to the above subset of patients.
Primary Efficacy Endpoints:
Secondary Efficacy Endpoints:
Excess Weight loss at 3, 6, 12 months
Eating behaviour at 3,6,12 months
Incidence of Vomiting
Fill frequency and outcome
Due to the significant amount of data that is currently contained in the North Eastern Weightloss Surgery database I have decided to narrow the parameters to the following for this particular study:
o All patients will be broken into two arms, one control arm and one trial arm.
o The outcomes that will be looked for are:
Number of adjustments per patient
Efficacy of the adjustments
Excess Weight Loss (EWL)
Eating behaviour and its changes
Food tolerances (as per the Moore-Bohn Food tolerance scale)
Safety Considerations and Reporting There are no safety considerations relating tho the use of the VEW questionnaire
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
361 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal